Phenotypic correlates of structural and functional protein impairments resultant from ALDH5A1 variants

• Verfasst von: Tokatly Latzer, Itay [VerfasserIn]
• Verfasst von: Roullet, Jean-Baptiste [VerfasserIn]
• Verfasst von: Cesaro, Samuele [VerfasserIn]
• Verfasst von: DiBacco, Melissa L. [VerfasserIn]
• Verfasst von: Arning, Erland [VerfasserIn]
• Verfasst von: Rotenberg, Alexander [VerfasserIn]
• Verfasst von: Lee, Henry H. C. [VerfasserIn]
• Verfasst von: Opladen, Thomas [VerfasserIn]
• Verfasst von: Jeltsch, Kathrin [VerfasserIn]
• Verfasst von: García-Cazorla, Àngels [VerfasserIn]
• Verfasst von: Juliá-Palacios, Natalia [VerfasserIn]
• Verfasst von: Gibson, K. Michael [VerfasserIn]
• Verfasst von: Bertoldi, Mariarita [VerfasserIn]
• Verfasst von: Pearl, Phillip L. [VerfasserIn]
• Titel: Phenotypic correlates of structural and functional protein impairments resultant from ALDH5A1 variants
• Verf.angabe: Itay Tokatly Latzer, Jean-Baptiste Roullet, Samuele Cesaro, Melissa L. DiBacco, Erland Arning, Alexander Rotenberg, Henry H. C. Lee, Thomas Opladen, Kathrin Jeltsch, Àngels García-Cazorla, Natalia Juliá-Palacios, K. Michael Gibson, Mariarita Bertoldi, Phillip L. Pearl
• E-Jahr: 2023
• Jahr: 14 November 2023
• Umfang: 22 S.
• Fussnoten: Gesehen am 23.04.2024
• Titel Quelle: Enthalten in: Human genetics
• Ort Quelle: Berlin : Springer, 1976
• Jahr Quelle: 2023
• Band/Heft Quelle: 142(2023), 12, Seite 1755-1776
• ISSN Quelle: 1432-1203
• DOI: doi:10.1007/s00439-023-02613-6
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1886542252

Abstract

To investigate the genotype-to-protein-to-phenotype correlations of succinic semialdehyde dehydrogenase deficiency (SSADHD), an inherited metabolic disorder of γ-aminobutyric acid catabolism. Bioinformatics and in silico mutagenesis analyses of ALDH5A1 variants were performed to evaluate their impact on protein stability, active site and co-factor binding domains, splicing, and homotetramer formation. Protein abnormalities were then correlated with a validated disease-specific clinical severity score and neurological, neuropsychological, biochemical, neuroimaging, and neurophysiological metrics. A total of 58 individuals (1:1 male/female ratio) were affected by 32 ALDH5A1 pathogenic variants, eight of which were novel. Compared to individuals with single homotetrameric or multiple homo and heterotetrameric proteins, those predicted not to synthesize any functional enzyme protein had significantly lower expression of ALDH5A1 (p = 0.001), worse overall clinical outcomes (p = 0.008) and specifically more severe cognitive deficits (p = 0.01), epilepsy (p = 0.04) and psychiatric morbidity (p = 0.04). Compared to individuals with predictions of having no protein or a protein impaired in catalytic functions, subjects whose proteins were predicted to be impaired in stability, folding, or oligomerization had a better overall clinical outcome (p = 0.02) and adaptive skills (p = 0.04). The quantity and type of enzyme proteins (no protein, single homotetramers, or multiple homo and heterotetramers), as well as their structural and functional impairments (catalytic or stability, folding, or oligomerization), contribute to phenotype severity in SSADHD. These findings are valuable for assessment of disease prognosis and management, including patient selection for gene replacement therapy. Furthermore, they provide a roadmap to determine genotype-to-protein-to-phenotype relationships in other autosomal recessive disorders.